Production of polypeptides

Details Production of polypeptides Production of polypeptides

2007-11-13

2007-11-13

Carlson, Karen Cochrane (Department: 1656)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

Reexamination Certificate

active

11213308

ABSTRACT:
An improved system for large scale production of proteins and/or polypeptides in cell culture, particularly in media characterized by one or more of: i) a cumulative amino acid concentration greater than about 70 mM; ii) a molar cumulative glutamine to cumulative asparagine ratio of less than about 2; iii) a molar cumulative glutamine to cumulative total amino acid ratio of less than about 0.2; iv) a molar cumulative inorganic ion to cumulative total amino acid ratio between about 0.4 to 1; or v) a combined cumulative glutamine and cumulative asparagine concentration between about 16 and 36 mM, is provided. The use of such a system allows high levels of protein production and lessens accumulation of certain undesirable factors such as ammonium and/or lactate. Additionally, culture methods including a temperature shift, typically including a decrease in temperature when the culture has reached about 20-80% of it maximal cell density, are provided. Alternatively or additionally, the present invention provides methods such that, after reaching a peak, lactate and/or ammonium levels in the culture decrease over time.

REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4522811 (1985-06-01), Eppstein et al.
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5122469 (1992-06-01), Mather et al.
patent: 5156964 (1992-10-01), Inlow et al.
patent: 5395760 (1995-03-01), Smith et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5538983 (1996-07-01), Buxbaum et al.
patent: 5589154 (1996-12-01), Anderson
patent: 5605690 (1997-02-01), Jacobs et al.
patent: 5658754 (1997-08-01), Kawasaki
patent: 5672502 (1997-09-01), Birch et al.
patent: 5705364 (1998-01-01), Etcheverry et al.
patent: 5712155 (1998-01-01), Smith et al.
patent: 5721121 (1998-02-01), Etcheverry et al.
patent: 5856179 (1999-01-01), Chen et al.
patent: 5871999 (1999-02-01), Boraston
patent: 5874060 (1999-02-01), Armour et al.
patent: 5976833 (1999-11-01), Furukawa et al.
patent: 6048728 (2000-04-01), Inlow et al.
patent: 6180401 (2001-01-01), Chen et al.
patent: 6291159 (2001-09-01), Winter et al.
patent: 6310185 (2001-10-01), Wallace et al.
patent: 6518415 (2003-02-01), Armour et al.
patent: 6572852 (2003-06-01), Smith et al.
patent: 6657103 (2003-12-01), Kucherlapati et al.
patent: 2004/0048368 (2004-03-01), Chen et al.
patent: 2006/0121569 (2006-06-01), Drapeau et al.
patent: 2006/0160180 (2006-07-01), Drapeau et al.
patent: 0117058 (1984-01-01), None
patent: 0117060 (1984-01-01), None
patent: 0171496 (1985-03-01), None
patent: 0173494 (1985-08-01), None
patent: 0239400 (1987-03-01), None
patent: 0417563 (1990-08-01), None
patent: 0417014 (1990-09-01), None
patent: 0481791 (1991-10-01), None
patent: 2177096 (1987-01-01), None
patent: 2251249 (1992-07-01), None
patent: 7165799 (1995-06-01), None
patent: WO92/06193 (1992-04-01), None
patent: WO93/05145 (1993-03-01), None
patent: WO95/24484 (1995-09-01), None
patent: WO96/39488 (1996-12-01), None
patent: WO98/45411 (1998-10-01), None
patent: WO 00/23082 (2000-04-01), None
patent: WO 00/72880 (2000-12-01), None
patent: WO 02/46237 (2002-06-01), None
patent: WO 02/046237 (2002-06-01), None
patent: WO 02/088306 (2002-11-01), None
patent: WO 02/088307 (2002-11-01), None
patent: WO 02/101019 (2002-12-01), None
patent: WO 03/027248 (2003-04-01), None
patent: WO 03/077858 (2003-09-01), None
patent: WO 2006/026445 (2006-03-01), None
U.S. Appl. No. 03/087,372, filed May 8, 2003, DelaCruz et al.
U.S. Appl. No. 03/104,406, filed Jun. 5, 2003, Wolfman et al.
U.S. Appl. No. 03/162,714, filed Aug. 28, 2003, Hill et al.
U.S. Appl. No. 03/180,308, filed Sep. 25, 2003, Hill et al.
U.S. Appl. No. 04/082,764, filed Apr. 29, 2004, Kunz et al.
U.S. Appl. No. 04/142,382, filed Jul. 22, 2004, Veldman et al.
U.S. Appl. No. 04/223,966, filed Nov. 11, 2004, Wolfman et al.
U.S. Appl. No. 05/106,154, filed May 19, 2005, Hill et al.
Abe et al., “The Monoclonal Antibody Directed To Difucosylated Type 2 Chain (Fucα1→2Galβ1→4[Fucα1→3]GlcNAc; Y Determinant),”J. Biol. Chem., 258: 11793-11797, 1983.
Altamirano, et al., “Improvement Of CHO Cell Culture Medium Formulation: Simultaneous Substitution Of Glucose And Glutamine,”Biotechnol. Prog., 16: 69-75, 2000.
Altamirano, et al., “Analysis Of CHO Cell Metabolic Redistribution In A Glutamate-Based Defined Medium In Continuous Culutre,”Biotechnol. Prog., 17: 1032-1041, 2001.
Bogheart et al., “Antibody-targeted Chemotherapy With The Calicheamicin Conjugate hu3S193-N-acetyl gamma Calicheamicin Dimethyl Hydrazide Targets Lewisy And Eliminates Lewisy-positive Human Carcinoma Cells And Xenografts,”Clin. Can. Res.10: 4538-49, 2004.
Boshart et al., “A Very Strong Enhancer Is Located Upstream Of An Immediate Early Gene Of Human Cytomegalovirus,”Cell41: 521-530, 1985.
Christie and Butler, “The Adaptation Of BHK Cells To A Non-Ammoniagenic Glutamate-Based Culture Medium,”Biotechn. And Bioeng., 64(3): 298-309, 1999.
Deutscher, “Setting Up A Laboratory,”Methods in Enzymology, 182: 19-23, 1990.
Deutscher, “Maintaining Protein Stability,”Methods in Enzymology, 182: 83-89, 1990.
Deutscher, “Rethinking Your Purification Procedure,”Methods in Enzymology, 182: 779-780, 1990.
DeVries et al. “Thefms-Like Tyrosine Kinase, A Receptor For Vascular Endothelial Growth Factor,”Science255: 989-991, 1992.
Dijkema et al., “Cloning And Expression Of The Chromosomal Immune Interferon Gene Of The Rat,”EMBO J.4(3): 761-767, 1985.
Drews, “Genomic Sciences And The Medicine Of Tomorrow,”Nature Biotechnology, 14: 1516-1518, 1996.
Gething et al., “Cell-surface Expression Of Influenza Haemagglutinin From A Cloned DNA Copy Of The RNA Gene,”Nature, 293: 620-625, 1981.
Gorfien, et al., “Optimized Nutrient Additives For Fed-Batch Cultures,”BioPharm International, 34-40, 2003.
Gorman et al., “The Rous Sarcoma Virus Long Terminal Repeat Is A Strong Promoter When Introduced Into A Variety Of Eukaryotic Cells By DNA-mediated Transfection,”Proc. Natl. Acad. Sci. USA79: 6777-6781, 1982.
Graham and van der Erb, “A New Technique For The Assay Of Infectivity Of Human Adenovirus 5 DNA,”Virology, 52: 456-457, 1973.
Graham et al., “Characteristics Of A Human Cell Line Transformed By DNA From Human Adenvirus Type 5,”J. Gen Virol., 36: 59-74, 1977.
Ham, “Clonal Growth Of Mammalian Cells In A Chemically Defined, Synthetic Medium,”Proc. Nat. Assoc. Sci. USA, 53: 288-293, 1965.
Jones et al., “Replacing The Complementarity-determining Regions In A Human Antibody With Those From A Mouse,”Nature321: 522-525, 1986.
Keown et al., “Methods For Introducing DNA Into Mammalian Cells,”Methods in Enzymology, 185: 527-537, 1990.
Kozbor et al., “The Production Of Monoclonal Antibodies From Human Lymphocytes,”Immunology Today, 4: 72-79, 1983.
Ling, et al., “Chemically Characterized Concentrated Corodies For Continuous Cell Culture (The 7C's Culture Media),”Experimental Cell Research, 52: 469-489, 1968.
Mansour et al., “Disruption Of The Proto-oncogeneint-2 In Mouse Embryo-derived Stem Cells: A General Strategy For Targeting Mutations To Non-selectable Genes,”Nature, 336: 348-352, 1988.
Mantei et al., “Rabbit β-globin mRNA Production In Mouse L Cells Transformed With Cloned Rabbit β-globin Chromosomal DNA,”Nature, 281: 40-46, 1979.
Mather, “Establishment And Characterization Of Two Distinct Mouse Testicular Epithelial Cell Lines,”Biol. Reprod., 23: 243-252, 1980.
Mather et al., “Culture Of Testicular Cells In Hormone-supplemented Serum-free Medium,”Annals N.Y. Acad. Sci., 383: 44-68, 1982.
Milligan and Rees, “Chimaeric Gα Proteins: Their Potential Use In Drug Discovery,”TIPS, 20: 118-124, 1999.
Milstein and Cuello, “Hybrid Hybridomas And Their Use

Affiliated with

Also associated with

Rating

Production of polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3856846